The national lockdown has hit pharmaceutical companies hard as restrictions on movement of goods and people imposed by the police led to a disruption in their supply chain, potentially blunting India's fight against Covid-19.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3dp9rUJ
via IFTTT
0 comments:
Post a Comment